Melanoma March is around the corner
2 February 2015
Our fourth annual Melanoma March is fast approaching and with 23 marches happening all over Australia; it is almost time to march for a cure and help us raise over $1 million for vital melanoma research.
Thanks to everyone who has already registered to march in 2015 and has been fundraising to help us reach our goal. Imagine what $1 million could do for melanoma research.
Melanoma March will officially launch with its first marches happening on the 22nd February and continue throughout the month of March with people getting involved all around the country. If you register before the 20th February, you will go into a draw to win a $500 fuel voucher.
You can also help raise money by buying a raffle ticket for only $10 for your chance to win a Toyota Yaris.
Sunday, 22 February 2015 - Melbourne
Sunday, 22 February 2015 -Wollongong
Saturday, 28 February 2015 - Bribie Island
Sunday, 8 March 2015 - Bunbury
Sunday, 15 March 2015 - Canberra
Saturday, 21 March 2015 -Gosford
Saturday, 21 March 2015 - Taree
Sunday, 22 March 2015 - Adelaide
Sunday, 22 March 2015 - Bathurst
Sunday, 22 March 2015 - Bonny Hills
Sunday, 22 March 2015 - Brisbane
Sunday, 22 March 2015 - Cairns
Sunday, 22 March 2015 - Coolangatta
Sunday, 22 March 2015 - Darwin
Sunday, 22 March 2015 - Perth
Sunday, 22 March 2015 - Manly
Sunday, 22 March 2015 - Rockingham
Sunday, 22 March 2015 - Townsville
Sunday, 22 March 2015 - Wagga Wagga
Sunday, 22 March 2015 - Perth
Sunday, 29 March 2015 - Busselton
Sunday, 29 March 2015 - Karratha
Sunday, 29 March 2015 - Picton
The ESMO conference provided a platform for announcing a number of key melanoma research findings - including practice-changing research from MIA.
Australian researchers have successfully trialled a combination of new treatments to prevent melanoma from spreading to distant organs.
A new treatment that combines an antibody with a cancer-killing virus improves outcomes for patients with advanced melanoma, an international clinical trial has shown.
It feels like groundhog day - another reality TV show, another batch of blatantly sunburnt contestants.
Wouldn’t it be great if your doctor could know if you would respond to treatment before you even had it?
In our latest research update we showcase research in survival estimates, uncover biomarkers, and reveal practice-changing research in surgery and medical oncology.
Senior Clinical Trial Coordinators, like Sarah Lane, support melanoma patients throughout the clinical trial process.
Melanomas are often hard to differentiate from moles. But new technology is helping to improve accuracy of diagnosis.
We are excited to announce that SunSense will proudly be an official supporter of Melanoma Institute Australia. SunSense is an Australian, family owned business.
Five years ago Julie Randall was diagnosed with melanoma and was given months to live. The melanoma had spread throughout her body. The doctors said it was incurable and she’d be lucky if she survived the next nine months. Julie, a patient at Melanoma Institute Australia under Professor Georgina Long was placed on an experimental drug trial. To watch the entire program, visit 9now.com or click here.
Meet our latest Surgical Oncology Fellow, Eva Nagy, to find out more about life as a surgical oncologist, why she came to MIA and what she hopes to achieve.
Melanoma research at ASCO this year focussed on the more precise use of current treatments to ensure optimal treatment for each patient.
MIA recently demonstrated that reflectance confocal microscopy is a useful tool in the clinic to diagnose suspicious-looking lesions in the mouth.
New research is likely to change the way melanoma is managed in many patients by reducing the need for major surgery and its associated morbidity and cost.
Researchers from MIA will present their latest research findings to the world’s largest oncology conference in early June.
Australian researchers pioneer life-extending treatment for advanced melanoma patients with brain tumours
Australian researchers are the first to demonstrate that patients with advanced melanoma which has spread to the brain can have increased life expectancy and possibly even beat the disease.
Melanoma March 2017 - that's a wrap! Thank you to everyone that helped make it happen.
Thank you so much to all those who contributed in a variety of ways to Melanoma March 2017 in 17 different locations and more around the country! You have contributed to getting the Big Data for Melanoma national Research Project happening!
By looking at the ‘dark matter’ of the genome, new research has found that genetic changes in acral and mucosal melanoma are completely different to mutations found in skin melanoma.